For those following the Vytorin issue: The Committee on Energy and Commerce that has been investigating the ENHANCE trial documents issued a press statement yesterday, saying it had written the CEO of Schering-Plough Corporation and Merck & Co, Inc., requesting additional information about the ENHANCE study trial after uncovering in company documents “serious concerns about the handling of the
